LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,854 | -75.5% | 81 | -70.5% | 0.00% | – |
| Q2 2023 | $19,828 | -4.1% | 275 | -2.1% | 0.00% | – |
| Q1 2023 | $20,670 | +759.5% | 281 | +680.6% | 0.00% | – |
| Q4 2022 | $2,405 | -51.9% | 36 | -30.8% | 0.00% | – |
| Q3 2022 | $5,000 | -16.7% | 52 | -20.0% | 0.00% | – |
| Q2 2022 | $6,000 | -25.0% | 65 | -11.0% | 0.00% | – |
| Q1 2022 | $8,000 | -83.3% | 73 | -76.6% | 0.00% | – |
| Q4 2021 | $48,000 | +26.3% | 312 | +16.4% | 0.00% | – |
| Q3 2021 | $38,000 | -66.7% | 268 | -69.1% | 0.00% | – |
| Q2 2021 | $114,000 | -18.6% | 868 | -5.1% | 0.00% | – |
| Q1 2021 | $140,000 | +337.5% | 915 | +180.7% | 0.00% | – |
| Q4 2020 | $32,000 | -73.3% | 326 | -74.1% | 0.00% | – |
| Q3 2020 | $120,000 | -17.8% | 1,259 | -3.5% | 0.00% | – |
| Q2 2020 | $146,000 | +5.0% | 1,304 | -31.7% | 0.00% | – |
| Q1 2020 | $139,000 | -32.5% | 1,910 | -3.0% | 0.00% | -100.0% |
| Q4 2019 | $206,000 | -8.4% | 1,970 | -12.9% | 0.00% | 0.0% |
| Q3 2019 | $225,000 | -38.7% | 2,263 | -29.7% | 0.00% | 0.0% |
| Q2 2019 | $367,000 | -15.2% | 3,219 | -6.5% | 0.00% | 0.0% |
| Q1 2019 | $433,000 | -68.0% | 3,444 | -65.4% | 0.00% | -75.0% |
| Q4 2018 | $1,354,000 | -37.0% | 9,966 | +27.3% | 0.00% | -33.3% |
| Q3 2018 | $2,149,000 | -6.8% | 7,831 | -29.6% | 0.01% | -14.3% |
| Q2 2018 | $2,305,000 | +36.6% | 11,130 | +9.0% | 0.01% | +40.0% |
| Q1 2018 | $1,687,000 | +12.2% | 10,214 | -7.0% | 0.01% | 0.0% |
| Q4 2017 | $1,503,000 | +29.3% | 10,978 | +28.7% | 0.01% | +25.0% |
| Q3 2017 | $1,162,000 | +131.0% | 8,531 | +105.9% | 0.00% | +100.0% |
| Q2 2017 | $503,000 | +23.6% | 4,144 | +7.8% | 0.00% | +100.0% |
| Q1 2017 | $407,000 | +6.0% | 3,845 | +1.8% | 0.00% | 0.0% |
| Q4 2016 | $384,000 | +33.8% | 3,778 | +34.0% | 0.00% | 0.0% |
| Q3 2016 | $287,000 | +70.8% | 2,819 | +100.2% | 0.00% | 0.0% |
| Q2 2016 | $168,000 | +93.1% | 1,408 | +73.4% | 0.00% | – |
| Q1 2016 | $87,000 | 0.0% | 812 | +1.4% | 0.00% | – |
| Q4 2015 | $87,000 | +58.2% | 801 | +23.2% | 0.00% | – |
| Q3 2015 | $55,000 | -6.8% | 650 | +11.9% | 0.00% | – |
| Q2 2015 | $59,000 | +47.5% | 581 | +13.5% | 0.00% | – |
| Q1 2015 | $40,000 | +17.6% | 512 | -18.7% | 0.00% | – |
| Q4 2014 | $34,000 | -53.4% | 630 | -59.3% | 0.00% | – |
| Q3 2014 | $73,000 | -75.4% | 1,549 | -67.5% | 0.00% | -100.0% |
| Q2 2014 | $297,000 | -14.7% | 4,769 | -7.9% | 0.00% | 0.0% |
| Q1 2014 | $348,000 | +68.9% | 5,180 | +31.5% | 0.00% | 0.0% |
| Q4 2013 | $206,000 | +357.8% | 3,940 | +274.9% | 0.00% | – |
| Q3 2013 | $45,000 | – | 1,051 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |